chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: same night she had chills; fever of 103degF; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (same night she had chills) and PYREXIA (fever of 103degF) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) at an unspecified dose. On an unknown date, the patient experienced CHILLS (same night she had chills) and PYREXIA (fever of 103degF). At the time of the report, CHILLS (same night she had chills) and PYREXIA (fever of 103degF) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia (99.5-100.9 °F): 103 °F High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Diarrhoea, Dysuria, Fatigue, Groin pain
Clinical narrative: at night the pain began to settle on the lower back where hips meet back; Feels like it was swollen to the point where she couldn't bend, move, or lift; back aching; diarrhea; washed out; high fever for an adult that peaked at 102.5 with increasing headache; groin lymph nodes are really sore and aching; high fever for an adult that peaked at 102.5 with increasing headache; pulling pain near her groin and had some trouble urinating; pulling pain near her groin and had some trouble urinating; This spontaneous case was reported by a consumer and describes the occurrence of GROIN PAIN (pulling pain near her groin and had some trouble urinating), DYSURIA (pulling pain near her groin and had some trouble urinating), BACK PAIN (back aching), DIARRHOEA (diarrhea) and BACK PAIN (at night the pain began to settle on the lower back where hips meet back) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced GROIN PAIN (pulling pain near her groin and had some trouble urinating) and DYSURIA (pulling pain near her groin and had some trouble urinating). On 25-Mar-2021, the patient experienced HEADACHE (high fever for an adult that peaked at 102.5 with increasing headache), LYMPH NODE PAIN (groin lymph nodes are really sore and aching) and PYREXIA (high fever for an adult that peaked at 102.5 with increasing headache). On 26-Mar-2021, the patient experienced BACK PAIN (back aching), DIARRHOEA (diarrhea) and FATIGUE (washed out). On 27-Mar-2021, the patient experienced BACK PAIN (at night the pain began to settle on the lower back where hips meet back) and SWELLING (Feels like it was swollen to the point where she couldn't bend, move, or lift). At the time of the report, GROIN PAIN (pulling pain near her groin and had some trouble urinating), DYSURIA (pulling pain near her groin and had some trouble urinating), BACK PAIN (back aching), DIARRHOEA (diarrhea), BACK PAIN (at night the pain began to settle on the lower back where hips meet back), SWELLING (Feels like it was swollen to the point where she couldn't bend, move, or lift), HEADACHE (high fever for an adult that peaked at 102.5 with increasing headache), LYMPH NODE PAIN (groin lymph nodes are really sore and aching), PYREXIA (high fever for an adult that peaked at 102.5 with increasing headache) and FATIGUE (washed out) outcome was unknown.            No Concomitant medications were provided. Treatment information included Advil.   This case was linked to MOD-2021-064849 (Patient Link).
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Lymph node pain, Pyrexia, Swelling
Clinical narrative: at night the pain began to settle on the lower back where hips meet back; Feels like it was swollen to the point where she couldn't bend, move, or lift; back aching; diarrhea; washed out; high fever for an adult that peaked at 102.5 with increasing headache; groin lymph nodes are really sore and aching; high fever for an adult that peaked at 102.5 with increasing headache; pulling pain near her groin and had some trouble urinating; pulling pain near her groin and had some trouble urinating; This spontaneous case was reported by a consumer and describes the occurrence of GROIN PAIN (pulling pain near her groin and had some trouble urinating), DYSURIA (pulling pain near her groin and had some trouble urinating), BACK PAIN (back aching), DIARRHOEA (diarrhea) and BACK PAIN (at night the pain began to settle on the lower back where hips meet back) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 046A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event.   On 24-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Feb-2021, the patient experienced GROIN PAIN (pulling pain near her groin and had some trouble urinating) and DYSURIA (pulling pain near her groin and had some trouble urinating). On 25-Mar-2021, the patient experienced HEADACHE (high fever for an adult that peaked at 102.5 with increasing headache), LYMPH NODE PAIN (groin lymph nodes are really sore and aching) and PYREXIA (high fever for an adult that peaked at 102.5 with increasing headache). On 26-Mar-2021, the patient experienced BACK PAIN (back aching), DIARRHOEA (diarrhea) and FATIGUE (washed out). On 27-Mar-2021, the patient experienced BACK PAIN (at night the pain began to settle on the lower back where hips meet back) and SWELLING (Feels like it was swollen to the point where she couldn't bend, move, or lift). At the time of the report, GROIN PAIN (pulling pain near her groin and had some trouble urinating), DYSURIA (pulling pain near her groin and had some trouble urinating), BACK PAIN (back aching), DIARRHOEA (diarrhea), BACK PAIN (at night the pain began to settle on the lower back where hips meet back), SWELLING (Feels like it was swollen to the point where she couldn't bend, move, or lift), HEADACHE (high fever for an adult that peaked at 102.5 with increasing headache), LYMPH NODE PAIN (groin lymph nodes are really sore and aching), PYREXIA (high fever for an adult that peaked at 102.5 with increasing headache) and FATIGUE (washed out) outcome was unknown.            No Concomitant medications were provided. Treatment information included Advil.   This case was linked to MOD-2021-064849 (Patient Link).
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Adverse reaction, Chills, Headache, Migraine, Pyrexia
Clinical narrative: Terrible headache; Headache is migraine quality; Rough side effects; Chills; Slight fever; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills), ADVERSE REACTION (Rough side effects), PYREXIA (Slight fever), HEADACHE (Terrible headache) and MIGRAINE (Headache is migraine quality) in a 39-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 27-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, the patient experienced CHILLS (Chills) and PYREXIA (Slight fever). On an unknown date, the patient experienced ADVERSE REACTION (Rough side effects), HEADACHE (Terrible headache) and MIGRAINE (Headache is migraine quality). At the time of the report, CHILLS (Chills), ADVERSE REACTION (Rough side effects), PYREXIA (Slight fever) and MIGRAINE (Headache is migraine quality) had not resolved and HEADACHE (Terrible headache) outcome was unknown.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea
Clinical narrative: Headache; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Headache) and NAUSEA (Nausea) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 382A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced HEADACHE (Headache) and NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, HEADACHE (Headache) and NAUSEA (Nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.    Most recent FOLLOW-UP information incorporated above includes: On 24-May-2021: Follow up received on 24-MAY-2021 does not contain any new information
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HERPES ZOSTER (shingles) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. UNK) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced HERPES ZOSTER (shingles). At the time of the report, HERPES ZOSTER (shingles) outcome was unknown. Not Provided          Concomitant information was not provided. Treatment information was not provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Vision blurred
Clinical narrative: blurred vision; strong headache; This spontaneous case was reported by a consumer and describes the occurrence of VISION BLURRED (blurred vision) and HEADACHE (strong headache) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VISION BLURRED (blurred vision) and HEADACHE (strong headache). At the time of the report, VISION BLURRED (blurred vision) and HEADACHE (strong headache) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided. Concomitant product use was not provided by the reporter.   This case was linked to MOD-2021-121772, MOD-2021-121772 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 11-May-2021: Event outcome updated.
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pain, Pyrexia
Clinical narrative: Ache/Pain; Fatigue; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (Ache/Pain), FATIGUE (Fatigue) and PYREXIA (Fever) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN (Ache/Pain), FATIGUE (Fatigue) and PYREXIA (Fever). At the time of the report, PAIN (Ache/Pain), FATIGUE (Fatigue) and PYREXIA (Fever) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter. Treatment information was not provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site pain
Clinical narrative: Pain in left arm; Tenderness on injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in left arm) and VACCINATION SITE PAIN (Tenderness on injection site) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 29-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in left arm) and VACCINATION SITE PAIN (Tenderness on injection site). The patient was treated with PARACETAMOL (TYLENOL) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Pain in left arm) and VACCINATION SITE PAIN (Tenderness on injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Follow-up information received on 12-May-2021 contains information regarding the route of Moderna vaccine.
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test, SARS-CoV-2 test positive
Clinical narrative: COVID positive; This spontaneous case was reported by a consumer and describes the occurrence of SARS-COV-2 TEST POSITIVE (COVID positive) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040A21A) for COVID-19 vaccination.     no medical history was reported by reporter.  Concomitant products included METOPROLOL SUCCINATE (TOPROL), HCTZ, VENLAFAXINE HYDROCHLORIDE (EFFEXOR) and LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced SARS-COV-2 TEST POSITIVE (COVID positive). At the time of the report, SARS-COV-2 TEST POSITIVE (COVID positive) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Mar-2021, SARS-CoV-2 test: positive (Positive) tested positive for covid.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medicines include Steroid, antibiotic, inhaler
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Feeling abnormal, Headache, Myalgia, Pyrexia
Clinical narrative: To lay on it was uncomfortable; Sore arm; All her joint hurts; Extreme body ache; A really bad headache with light sensitivity; Fever of 104; Fever of 101; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (To lay on it was uncomfortable), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (All her joint hurts), MYALGIA (Extreme body ache) and HEADACHE (A really bad headache with light sensitivity) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concomitant products included INSULIN GLARGINE (LANTUS), INSULIN LISPRO (LISPRO INSULIN), DULOXETINE, DOXYCYCLINE, IRBESARTAN, TRAZODONE, LEVOTHYROXINE, ACETYLSALICYLIC ACID (ASPIRIN 81), PRAVASTATIN, BIOFLAVONOIDS NOS, VITAMINS NOS (LIPOFLAVONOID [BIOFLAVONOIDS NOS;VITAMINS NOS]), PREGABALIN, CARVEDILOL and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PYREXIA (Fever of 101). On an unknown date, the patient experienced FEELING ABNORMAL (To lay on it was uncomfortable), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (All her joint hurts), MYALGIA (Extreme body ache), HEADACHE (A really bad headache with light sensitivity) and PYREXIA (Fever of 104). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (To lay on it was uncomfortable), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (All her joint hurts), MYALGIA (Extreme body ache), HEADACHE (A really bad headache with light sensitivity), PYREXIA (Fever of 104) and PYREXIA (Fever of 101) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and Treatment medications were reported.   This case was linked.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up received on 01-jun-2021 and No new information is added
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: To lay on it was uncomfortable; Sore arm; All her joint hurts; Extreme body ache; A really bad headache with light sensitivity; Fever of 104; Fever of 101; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (To lay on it was uncomfortable), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (All her joint hurts), MYALGIA (Extreme body ache) and HEADACHE (A really bad headache with light sensitivity) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19. Concomitant products included INSULIN GLARGINE (LANTUS), INSULIN LISPRO (LISPRO INSULIN), DULOXETINE, DOXYCYCLINE, IRBESARTAN, TRAZODONE, LEVOTHYROXINE, ACETYLSALICYLIC ACID (ASPIRIN 81), PRAVASTATIN, BIOFLAVONOIDS NOS, VITAMINS NOS (LIPOFLAVONOID [BIOFLAVONOIDS NOS;VITAMINS NOS]), PREGABALIN, CARVEDILOL and VITAMIN D [VITAMIN D NOS] for an unknown indication.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced PYREXIA (Fever of 101). On an unknown date, the patient experienced FEELING ABNORMAL (To lay on it was uncomfortable), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (All her joint hurts), MYALGIA (Extreme body ache), HEADACHE (A really bad headache with light sensitivity) and PYREXIA (Fever of 104). The patient was treated with PARACETAMOL (TYLENOL) at a dose of 1 dosage form; ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form and IBUPROFEN (ADVIL [IBUPROFEN]) at a dose of 1 dosage form. At the time of the report, FEELING ABNORMAL (To lay on it was uncomfortable), VACCINATION SITE PAIN (Sore arm), ARTHRALGIA (All her joint hurts), MYALGIA (Extreme body ache), HEADACHE (A really bad headache with light sensitivity), PYREXIA (Fever of 104) and PYREXIA (Fever of 101) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications and Treatment medications were reported.   This case was linked.   Most recent FOLLOW-UP information incorporated above includes: On 01-Jul-2021: Follow-up received on 01-jun-2021 and No new information is added
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Headache, Pain in extremity
Clinical narrative: pain in left arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in left arm) and HEADACHE (headache) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in left arm) and HEADACHE (headache). The patient was treated with IBUPROFEN ongoing since an unknown date at a dose of 1 UNK. On 28-Feb-2021, PAIN IN EXTREMITY (pain in left arm) and HEADACHE (headache) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided.
Age: 51.0
Sex: M
Vaccine: COVID19
Symptoms: Back pain, Sciatica
Clinical narrative: bad case of sciatica pain; sciatica pain focused on back; This spontaneous case was reported by a consumer and describes the occurrence of SCIATICA (bad case of sciatica pain) and BACK PAIN (sciatica pain focused on back) in a 51-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SCIATICA (bad case of sciatica pain) and BACK PAIN (sciatica pain focused on back). The patient was treated with IBUPROFEN ongoing since an unknown date for Sciatica, at a dose of 1 dosage form and CORTISONE ongoing since an unknown date for Sciatica, at a dose of 1 dosage form. At the time of the report, SCIATICA (bad case of sciatica pain) and BACK PAIN (sciatica pain focused on back) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product information was not provided.  Consumer reported mild relief with treatment of ibuprofen.  Consumer visited a chiropractor on unknown date, and described receiving "like a cortisone injection."   Most recent FOLLOW-UP information incorporated above includes: On 30-Mar-2021: Vaccination site discomfort was removed from adverse events. Consumer report of "like a cortisone injection" was referring to a treatment only. On 27-Jul-2021: Patient demographics updated.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling cold, Somnolence
Clinical narrative: coldness; Sleepy; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (coldness), SOMNOLENCE (Sleepy) and FATIGUE (fatigue) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     Concomitant products included ATENOLOL, CLONAZEPAM, CITALOPRAM, FINASTERIDE, TAMSULOSIN HYDROCHLORIDE (FLOMAX RELIEF), VITAMIN B12 [VITAMIN B12 NOS] and ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) for an unknown indication.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Mar-2021, the patient experienced FEELING COLD (coldness), SOMNOLENCE (Sleepy) and FATIGUE (fatigue). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING COLD (coldness), SOMNOLENCE (Sleepy) and FATIGUE (fatigue) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Rash, Swelling
Clinical narrative: swelling; a little rash on right arm; rash on left arm; headache; This spontaneous case was reported by a consumer and describes the occurrence of SWELLING (swelling), RASH (a little rash on right arm), RASH (rash on left arm) and HEADACHE (headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to vaccine.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SWELLING (swelling), RASH (a little rash on right arm), RASH (rash on left arm) and HEADACHE (headache). At the time of the report, SWELLING (swelling), RASH (a little rash on right arm), RASH (rash on left arm) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported.No treatment information was provided.
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Blood cholesterol, Pain in extremity
Clinical narrative: sore arm; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (sore arm) in a 76-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007B21A and 022m20A) for COVID-19 vaccination.     Concomitant products included ATORVASTATIN CALCIUM (LIPITOR) for Cholesterol.   On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 29-Mar-2021 at 10:00 AM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Mar-2021, the patient experienced PAIN IN EXTREMITY (sore arm). The patient was treated with MEFENAMIC ACID (ADVIL [MEFENAMIC ACID]) in March 2021 for Pain in arm, at a dose of UNK dosage form. On 30-Mar-2021, PAIN IN EXTREMITY (sore arm) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood cholesterol: not provided Not provided.         Most recent FOLLOW-UP information incorporated above includes: On 26-May-2021: Follow up received on 26 May  2021 had updated address of reporter, additional information of patient, current condition of patient concomitant medication patient used to take, information regarding first dose of vaccine and vaccine facility, event outcome and stop date.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Bone pain, Chills, Dizziness, Fatigue
Clinical narrative: bones aching; dizzy; no kind of energy; a slight headache; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache) and CHILLS (Chills) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information provided. No Treatment information provided.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: bones aching; dizzy; no kind of energy; a slight headache; Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache) and CHILLS (Chills) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, the patient experienced BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache), CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, BONE PAIN (bones aching), DIZZINESS (dizzy), ASTHENIA (no kind of energy), HEADACHE (a slight headache), CHILLS (Chills) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant information provided. No Treatment information provided.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Myalgia, Pyrexia
Clinical narrative: achy; feverish; could hardly breathe good; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (could hardly breathe good), MYALGIA (achy) and PYREXIA (feverish) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 040A21A) for COVID-19 vaccination.     The patient's past medical history included Asthma and Allergy. Concomitant products included LEVOSALBUTAMOL HYDROCHLORIDE (XOPENEX) for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Mar-2021, the patient experienced DYSPNOEA (could hardly breathe good). On an unknown date, the patient experienced MYALGIA (achy) and PYREXIA (feverish). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, DYSPNOEA (could hardly breathe good) had resolved and MYALGIA (achy) and PYREXIA (feverish) had not resolved.            Treatment medications taken were antibiotics Action taken with mRNA-1273 in response to the events were Not Applicable
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Device connection issue, Exposure via skin contact, Incorrect dose administered
Clinical narrative: Don't know how much it got but a lot was on the arm; When pushing the dose more come out of the syringe, felt like the dose was coming out from; Don't know how much it got but a lot was on the arm; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPOSURE VIA SKIN CONTACT (Don't know how much it got but a lot was on the arm), DEVICE CONNECTION ISSUE (When pushing the dose more come out of the syringe, felt like the dose was coming out from) and INCORRECT DOSE ADMINISTERED (Don't know how much it got but a lot was on the arm) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 028A21A and 025A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 30-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Mar-2021, the patient experienced EXPOSURE VIA SKIN CONTACT (Don't know how much it got but a lot was on the arm), DEVICE CONNECTION ISSUE (When pushing the dose more come out of the syringe, felt like the dose was coming out from) and INCORRECT DOSE ADMINISTERED (Don't know how much it got but a lot was on the arm). On 30-Mar-2021, EXPOSURE VIA SKIN CONTACT (Don't know how much it got but a lot was on the arm), DEVICE CONNECTION ISSUE (When pushing the dose more come out of the syringe, felt like the dose was coming out from) and INCORRECT DOSE ADMINISTERED (Don't know how much it got but a lot was on the arm) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 02 march 2021 the patient received the first of the two planned doses of mRNA - 1273 (Lot no: 025A21A, Exp date: 8 /24/20 21) via intramuscular route on Left arm. Treatment information not provided. Concomitant medications were not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site induration, Peripheral swelling, Pruritus
Clinical narrative: Little bit itchiness; Solid about the size of 50 cents; Swelling on the left arm; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (Swelling on the left arm), PRURITUS (Little bit itchiness) and INJECTION SITE INDURATION (Solid about the size of 50 cents) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002B21A) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE SODIUM SESQUIHYDRATE (PROTONIX [PANTOPRAZOLE SODIUM SESQUIHYDRATE]) for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced PERIPHERAL SWELLING (Swelling on the left arm). On 30-Mar-2021, the patient experienced PRURITUS (Little bit itchiness) and INJECTION SITE INDURATION (Solid about the size of 50 cents). At the time of the report, PERIPHERAL SWELLING (Swelling on the left arm), PRURITUS (Little bit itchiness) and INJECTION SITE INDURATION (Solid about the size of 50 cents) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       For mRNA-1273 (Moderna COVID-19 Vaccine) (unknown), the reporter did not provide any causality assessments.  The patient developed swelling on the left arm one week post receiving the first dose. Initially there was a small reaction of swelling on next day, but it was subsided. On 30-Mar-2021, the swelling reappeared about the size of 50 cents and it was solid associated with little itchiness.  No treatment information was provided.
Age: 18.0
Sex: M
Vaccine: COVID19
Symptoms: Accidental overdose, Vaccination site pain
Clinical narrative: Both arms were hurting; Patient received two vaccines in one day (left and right arm); This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ACCIDENTAL OVERDOSE (Patient received two vaccines in one day (left and right arm)) and VACCINATION SITE PAIN (Both arms were hurting) in an 18-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003A21A and 003A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Mar-2021, the patient experienced ACCIDENTAL OVERDOSE (Patient received two vaccines in one day (left and right arm)). On an unknown date, the patient experienced VACCINATION SITE PAIN (Both arms were hurting). On 24-Mar-2021, ACCIDENTAL OVERDOSE (Patient received two vaccines in one day (left and right arm)) had resolved. At the time of the report, VACCINATION SITE PAIN (Both arms were hurting) outcome was unknown.            The patient reported that they received both their Moderna vaccines on 24-MAR-2021.   Reportedly, the patient received one shot in their left arm and one shot in the right arm by the same Pharmacist. The patient also stated that they didn't know that the patient was only supposed to receive one shot.  The Pharmacy also advised the patient to come back for their 3rd shot.  The patient also went to emergency room because both their arms were hurting.  No Concomitant product use was reported. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Overdose
Clinical narrative: Administered 1ml to five patients; This spontaneous case was reported by a nurse and describes the occurrence of OVERDOSE (Administered 1ml to five patients) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Mar-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 ml. On an unknown date, the patient experienced OVERDOSE (Administered 1ml to five patients). At the time of the report, OVERDOSE (Administered 1ml to five patients) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   The reporter was a Nurse who reported that they administered 1 ml to five patients on 30-Mar-2021 . The patients were monitored, and nurse planned to inform the patients that they received 1ml.  No Concomitant product use was reported. No treatment information was provided.   This case was linked to MOD-2021-062195 (Patient Link).
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hyperhidrosis, Nasopharyngitis, Nausea, Vaccination site erythema
Clinical narrative: Whole body became sweaty; Gets cold; Feels miserable; Nausea; Vaccination site erythema; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (Whole body became sweaty), NASOPHARYNGITIS (Gets cold), FEELING ABNORMAL (Feels miserable), NAUSEA (Nausea) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No Significant medical history).    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced HYPERHIDROSIS (Whole body became sweaty), NASOPHARYNGITIS (Gets cold), FEELING ABNORMAL (Feels miserable), NAUSEA (Nausea) and VACCINATION SITE ERYTHEMA (Vaccination site erythema). At the time of the report, HYPERHIDROSIS (Whole body became sweaty), NASOPHARYNGITIS (Gets cold), FEELING ABNORMAL (Feels miserable), NAUSEA (Nausea) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medicines include Extra Strength Tylenol
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness on injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Soreness on injection site) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 043L20A) for COVID-19 vaccination.     Concurrent medical conditions included Gout. Concomitant products included DIAZEPAM (VALIUM) for an unknown indication.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced VACCINATION SITE PAIN (Soreness on injection site). At the time of the report, VACCINATION SITE PAIN (Soreness on injection site) had resolved.            The patient with preexisting medical conditions on 24-Feb-2021 received their second dose and reported of having experienced soreness on the injection site similar symptoms, with same onset and remission that they experienced post receiving their first dose of vaccine. The patient had their first dose of Moderna COVID-19 vaccine on 27-Jan-2021 and experienced soreness on the injection site on the following day, which resolved in the span of approximately one day.  Concomitant medications reported by the patient also included gout medication and muscle relaxants. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not applicable   This case was linked to MOD-2021-064955 (Patient Link).
Age: 43.0
Sex: M
Vaccine: COVID19
Symptoms: Tinnitus
Clinical narrative: Ringing in my ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Ringing in my ears) in a 43-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     Concurrent medical conditions included Asthma and Cholesterol. Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR), ROSUVASTATIN, FLECAINIDE and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced TINNITUS (Ringing in my ears). At the time of the report, TINNITUS (Ringing in my ears) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The patient who received their first dose of the Moderna COVID-19 vaccine reported that within an hour, they could hear ringing in their ears. The patient reports that it got louder and was worse and stated they had this condition before.   The patient had an appointment with their doctor on 31-Mar-2021.  No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jul-2021: Follow Up received contains No new Information; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure increased, Fatigue
Clinical narrative: Increased blood pressure; Get tired after Meals; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE INCREASED (Increased blood pressure) and FATIGUE (Get tired after Meals) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013M20A) for COVID-19 vaccination.     Concurrent medical conditions included Acid reflux (esophageal).   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced BLOOD PRESSURE INCREASED (Increased blood pressure) and FATIGUE (Get tired after Meals). At the time of the report, BLOOD PRESSURE INCREASED (Increased blood pressure) and FATIGUE (Get tired after Meals) outcome was unknown.            The patient received their first dose of vaccine on 20-Jan-2021 and second dose on 18-Feb-2021. The patient did not have any side effects after both doses of the vaccine but during conversation, the patient reported possible adverse events and stated that the patient began to experience increased blood pressure and get tired after meals and these possible adverse events started on 26-Mar-2021.   Reportedly, the patient had a past history of acid reflux and was taking medication for it. On 30-Mar-2021, the patient would be going to urgent care to get evaluated.  Concomitant medication included medication for acid reflux.  No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 80.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Diarrhoea, Productive cough, Vaccination site pain
Clinical narrative: diarrhea; cough; phlegm; Vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (diarrhea), PAIN IN EXTREMITY (Sore arm), COUGH (cough) and PRODUCTIVE COUGH (phlegm) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Previously administered products included for an unreported indication: FLU. Concurrent medical conditions included Flu vaccination.    On 05-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Mar-2021, the patient experienced PAIN IN EXTREMITY (Sore arm). On 08-Mar-2021, the patient experienced DIARRHOEA (diarrhea), COUGH (cough) and PRODUCTIVE COUGH (phlegm). On 10-Mar-2021, DIARRHOEA (diarrhea), PAIN IN EXTREMITY (Sore arm), COUGH (cough) and PRODUCTIVE COUGH (phlegm) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported. Treatment information was not reported.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: The patient stated that she got both the shots of vaccine.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Electrocardiogram, Feeling abnormal, Headache, Hypersensitivity
Clinical narrative: sharp pain; the episodes repeat as the medication wears off; allergic reaction; sharp pain and numbness on the arms and legs; numbness on arms and legs; headache; palpitations; dizziness; Very very shaken; Tingling on the face and jaws; fuzzy; This spontaneous case was reported by a consumer and describes the occurrence of PALPITATIONS (palpitations), DIZZINESS (dizziness), TREMOR (Very very shaken), PARAESTHESIA (Tingling on the face and jaws) and FEELING ABNORMAL (fuzzy) in a 47-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Shellfish allergy and Penicillin allergy.    On 24-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Mar-2021, the patient experienced PALPITATIONS (palpitations), DIZZINESS (dizziness), TREMOR (Very very shaken), PARAESTHESIA (Tingling on the face and jaws), FEELING ABNORMAL (fuzzy), PAIN IN EXTREMITY (sharp pain and numbness on the arms and legs), HYPOAESTHESIA (numbness on arms and legs) and HEADACHE (headache). On an unknown date, the patient experienced HYPERSENSITIVITY (allergic reaction), PAIN (sharp pain) and VACCINATION COMPLICATION (the episodes repeat as the medication wears off). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 25 mg and PARACETAMOL (TYLENOL) at a dose of 1 dosage form. At the time of the report, PALPITATIONS (palpitations), DIZZINESS (dizziness), TREMOR (Very very shaken), PARAESTHESIA (Tingling on the face and jaws), FEELING ABNORMAL (fuzzy), HYPERSENSITIVITY (allergic reaction), PAIN IN EXTREMITY (sharp pain and numbness on the arms and legs), PAIN (sharp pain), VACCINATION COMPLICATION (the episodes repeat as the medication wears off), HYPOAESTHESIA (numbness on arms and legs) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal normal.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant products were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 18-May-2021: Non-Significant follow up received on 18-May-2021. Contact information updated.